Company Directory / biotechnology

K

PrivateFor profitbiotechnologyUnited Kingdom

Karus Therapeutics

Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.

Founded
2005
21 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$15M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

200519002026

21 years old.

Reach

No web traffic ranking listed.

What it does

BiotechnologyLife SciencePharmaceutical

Funding, as listed

$15M currency not stated

  • Rounds7
  • LatestSeries b, May 2016
  • Investors8, 4 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersPaul Townsend

Every detail we hold

Everything the source datasets list about Karus Therapeutics, field by field. Contact details are held but never shown.

The company

Name
Karus Therapeutics
Type
For profit
Status
Private
Founded
2005
Founders
Paul Townsend
Industry
biotechnology
Categories
Biotechnology, Life Science, Pharmaceutical

Where

Country
United Kingdom
Markets
Europe, Middle East, and Africa (EMEA)

Size and reach

Staff band
11-50

Funding, as listed

Total
14,753,207 (currency not stated)
Rounds
7
Latest round
Series b
Latest round date
May 2016
Investors
8
Lead investors
4
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Karus Therapeutics may be growing as it is mentioned in the context of a rapidly growing market for Epidermolysis Bullosa treatments, indicating a potentially expanding market presence. The company is also listed in a report on the global Histone Deacetylase (HDAC) Inhibitors market, suggesting active sales and market participation. Furthermore, Karus Therapeutics is included in discussions about the blepharitis pipeline industry, which is expected to witness significant growth from 2023 to 2029, implying that the company is involved in sectors that are experiencing an upward trend.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

biotechnology in United Kingdom.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.